Larkin Finbar 4
4 · Jazz Pharmaceuticals plc · Filed Mar 5, 2020
Insider Transaction Report
Form 4
Larkin Finbar
SVP, Technical Development
Transactions
- Sale
Ordinary Shares
2020-03-03$119.75/sh−279$33,410→ 14,790 total
Footnotes (1)
- [F1]Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.